A meta-analysis of 11 studies involving 1,209 women found that low-glycaemic index diets were associated with improved glucose measures, lower insulin resistance and fewer cases of excessively large babies, although the evidence remains limited.
A new meta-analysis published in DovePress adds to evidence that low-glycaemic index diets may help women with gestational diabetes improve blood sugar control and limit some pregnancy complications. Gestational diabetes develops during pregnancy when hormones from the placenta make the body less responsive to insulin, allowing glucose to rise in the bloodstream. Public health agencies including the US Centres for Disease Control and Prevention and Johns Hopkins Medicine say the condition usually appears midway through pregnancy and can carry risks for both mother and baby, including a greater chance of high birth weight, caesarean delivery and later type 2 diabetes.
The DovePress review pooled 11 studies involving 1,209 patients and found that low-glycaemic index, or low-GI, eating plans were associated with lower fasting glucose, lower two-hour post-meal glucose and a modest reduction in HbA1c, a measure of average blood sugar over time. The authors also reported improvement in insulin resistance and fewer cases of macrosomia, the term used when a baby is significantly larger than average at birth. Their analysis suggests that changing the type of carbohydrate consumed may matter as much as reducing carbohydrate overall, because lower-GI foods are digested more slowly and tend to blunt sharp spikes in blood sugar.
The findings matter because gestational diabetes is common enough to shape routine prenatal care. The National Institutes of Health says the condition affects up to about 9% of pregnancies in the United States, while Johns Hopkins Medicine puts the figure at roughly 3% to 8%. Risk rises with overweight or obesity, a family history of diabetes and previous large-birth-weight infants. Those risk factors help explain why nutrition advice is now a central part of treatment, rather than an optional add-on.
The review also fits with a broader clinical view that dietary intervention can reduce complications without medication in some patients. Earlier research cited by the authors has linked gestational diabetes with polyhydramnios, high blood pressure, pre-eclampsia and larger babies, while other studies have associated it with a higher risk of newborn hypoglycaemia and later metabolic disease in both mother and child. The meta-analysis does not prove that low-GI diets eliminate those risks, but it does strengthen the case that carefully planned meal patterns can improve day-to-day control and may reduce the likelihood of excess maternal weight gain during pregnancy.
Still, the authors caution that the evidence base remains relatively small and uneven. Their pooled results were drawn from studies that varied in size, diet design and follow-up length, which left some outcomes highly inconsistent across trials. That means low-GI advice is promising, but not definitive, and it is best viewed as one part of a broader management plan that includes glucose monitoring, clinical review and individualised nutrition support. Even so, the review reinforces a practical point that many clinicians already emphasise: in gestational diabetes, what a patient eats can have measurable effects on both blood sugar and pregnancy outcomes.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
